Showing results (1-10 of 140) with videos related to
Sort By:
Pageof 14
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 9, 2019
Sphingolipids and the unfolded protein responseMelissa K Bennett, Craig T Wallington-Beddoe, Stuart M PitsonBritish Journal of Haematology|April 21, 2018
Resistance to proteasome inhibitors and other targeted therapies in myelomaCraig T Wallington-Beddoe, Magdalena Sobieraj-Teague, Bryone J Kuss, et al.Cell Death Discovery|August 1, 2018
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.Cancer Research|April 2, 2014
Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expressionCraig T Wallington-Beddoe, Jason A Powell, Daochen Tong, et al.Journal of Hematology & Oncology|September 24, 2021
Prognostic and predictive biomarker developments in multiple myelomaCraig T Wallington-Beddoe, Rachel L MynottACS Pharmacology & Translational Science|June 21, 2021
Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple MyelomaRachel L Mynott, Craig T Wallington-BeddoeACS Pharmacology & Translational Science|April 16, 2021
Inhibition of P-Glycoprotein Does Not Increase the Efficacy of Proteasome Inhibitors in Multiple Myeloma CellsRachel L Mynott, Craig T Wallington-BeddoeBritish Journal of Haematology|March 26, 2013
Oncogenic properties of sphingosine kinases in haematological malignanciesCraig T Wallington-Beddoe, Kenneth F Bradstock, Linda J BendallAutophagy|April 5, 2011
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cellsCraig T Wallington-Beddoe, John Hewson, Kenneth F Bradstock, et al.Oncotarget|May 4, 2017
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stressCraig T Wallington-Beddoe, Melissa K Bennett, Kate Vandyke, et al.Pageof 14